Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
about
Vascular disrupting agent arsenic trioxide enhances thermoradiotherapy of solid tumors.Angiogenesis and vascular targeting: relevance for hyperthermia.Current status of antivascular therapy and targeted treatment in the clinic.The effect of mild temperature hyperthermia on tumour hypoxia and blood perfusion: relevance for radiotherapy, vascular targeting and imaging.Realistic biological approaches for improving thermoradiotherapy.Nanotherapeutics for enhancing thermal therapy of cancer.Commentary on classic paper in hyperthermic oncology 'Tumour oxygenation is increased by hyperthermia at mild temperatures' by CW Song et al., 1996The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization.Therapeutic potential of using the vascular disrupting agent OXi4503 to enhance mild temperature thermoradiation.Induction of hypoxia by vascular disrupting agents and the significance for their combination with radiation therapy.
P2860
Q35681405-FC81D65F-CAFB-4B3A-9344-262A3221BB7FQ37063496-67AAF65E-D148-432A-8E80-C7D04BE7FF01Q37063510-6902D572-0AAA-43B1-8C02-9A401F45B391Q37709394-76AC77C5-97FE-453C-9259-52751CD4F355Q38648236-C34C3204-84D6-47D8-94D1-D56A5A1ABA4AQ40063990-26CB52FA-FBE2-4210-BFA4-9445ACDDE0CDQ41825352-AB96A5ED-BC31-4F14-A09C-AF3C9A0D0225Q46882346-F7A2DF03-59D4-451C-8AED-22863BEF1023Q51029869-F3EC319A-EFE8-4571-8AEE-0A5E25437CB6Q51210513-FCCC8837-36D9-42E3-85F6-7C9CF3E4E23D
P2860
Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Tumour-specific enhancement of ...... ethylxanthenone-4-acetic acid.
@en
Tumour-specific enhancement of ...... ethylxanthenone-4-acetic acid.
@nl
type
label
Tumour-specific enhancement of ...... ethylxanthenone-4-acetic acid.
@en
Tumour-specific enhancement of ...... ethylxanthenone-4-acetic acid.
@nl
prefLabel
Tumour-specific enhancement of ...... ethylxanthenone-4-acetic acid.
@en
Tumour-specific enhancement of ...... ethylxanthenone-4-acetic acid.
@nl
P2860
P1476
Tumour-specific enhancement of ...... methylxanthenone-4-acetic acid
@en
P2093
P2860
P304
P356
10.1080/02656730310001619370
P577
2004-06-01T00:00:00Z